Predicting risk of severe hypoglycaemia in type 2 diabetes Sankalpa NeupaneMark L. Evans Commentary 21 March 2015 Pages: 1143 - 1145
Lessons from the mouse: potential contribution of bystander lymphocyte activation by viruses to human type 1 diabetes Jessica A. PaneBarbara S. Coulson Review 21 March 2015 Pages: 1149 - 1159
Biomarkers related to severe hypoglycaemia and lack of good glycaemic control in ACCORD Lisa S. ChowHaiying ChenElizabeth R. Seaquist Article 05 February 2015 Pages: 1160 - 1166
CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes Bruce BuckinghamPeiyao Chengfor the Diabetes Research in Children Network (DirecNet) and Type 1 Diabetes TrialNet Study Groups Article 14 March 2015 Pages: 1167 - 1174
Upper gastrointestinal motility and symptoms in individuals with diabetes, prediabetes and normal glucose tolerance Georgios C. BoronikolosBjörn A. MengeJuris J. Meier Article 01 March 2015 Pages: 1175 - 1182
Effects of canagliflozin on body weight and relationship to HbA1c and blood pressure changes in patients with type 2 diabetes William T. CefaluKaj StenlöfGary Meininger Short Communication 27 March 2015 Pages: 1183 - 1187
Experience of a serious life event increases the risk for childhood type 1 diabetes: the ABIS population-based prospective cohort study Maria NygrenJohn CarstensenAnneli Frostell Article 14 April 2015 Pages: 1188 - 1197
The impact of lifestyle intervention on sedentary time in individuals at high risk of diabetes Bonny Rockette-WagnerSharon Edelsteinfor the Diabetes Prevention Program Research Group Article 08 April 2015 Pages: 1198 - 1202
Blood pressure level and risk of major cardiovascular events and all-cause of mortality in patients with type 2 diabetes and renal impairment: an observational study from the Swedish National Diabetes Register Hanri AfghahiMaria K. SvenssonAnn-Marie Svensson Article 14 March 2015 Pages: 1203 - 1211
Long-term risk of type 2 diabetes mellitus in relation to BMI and weight change among women with a history of gestational diabetes mellitus: a prospective cohort study Wei BaoEdwina YeungCuilin Zhang Article 22 March 2015 Pages: 1212 - 1219
Birthweight, mediating biomarkers and the development of type 2 diabetes later in life: a prospective study of multi-ethnic women Yan SongYen-Tsung HuangSimin Liu Article 08 January 2015 Pages: 1220 - 1230
Common variants in or near ZNRF1, COLEC12, SCYL1BP1 and API5 are associated with diabetic retinopathy in Chinese patients with type 2 diabetes Danfeng PengJie WangWeiping Jia Article 28 March 2015 Pages: 1231 - 1238
A live-cell, high-content imaging survey of 206 endogenous factors across five stress conditions reveals context-dependent survival effects in mouse primary beta cells Yu Hsuan Carol YangQuin F. WillsJames D. Johnson Article Open access 14 March 2015 Pages: 1239 - 1249
Syntaxin-4 mediates exocytosis of pre-docked and newcomer insulin granules underlying biphasic glucose-stimulated insulin secretion in human pancreatic beta cells Li XieDan ZhuHerbert Y. Gaisano Article 13 March 2015 Pages: 1250 - 1259
The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells Annalisa NatalicchioFederica TortosaFrancesco Giorgino Article 26 March 2015 Pages: 1260 - 1271
Forkhead box O1 mediates defects in palmitate-induced insulin granule exocytosis by downregulation of calcium/calmodulin-dependent serine protein kinase expression in INS-1 cells Yao WangHaiyan LinXiao Han Article 22 March 2015 Pages: 1272 - 1281
Bone morphogenetic protein 4 inhibits insulin secretion from rodent beta cells through regulation of calbindin1 expression and reduced voltage-dependent calcium currents Gitte L. ChristensenMaria L. B. JacobsenNils Billestrup Article 02 April 2015 Pages: 1282 - 1290
Slow potentials encode intercellular coupling and insulin demand in pancreatic beta cells Fanny LebretonAntoine PirogJochen Lang Article 19 March 2015 Pages: 1291 - 1299
Islet transplantation from a nationally funded UK centre reaches socially deprived groups and improves metabolic outcomes Shareen ForbesNeil W. A. McGowanJohn J. Casey Article Open access 26 March 2015 Pages: 1300 - 1308
PD-1-dependent restoration of self-tolerance in the NOD mouse model of diabetes after transient anti-TCRβ mAb therapy Paul M. SchroderMithun KhattarStanislaw M. Stepkowski Article 21 March 2015 Pages: 1309 - 1318
Lack of the protein tyrosine phosphatase PTPN22 strengthens transplant tolerance to pancreatic islets in mice Georgia FousteriTatiana JofraManuela Battaglia Article 07 March 2015 Pages: 1319 - 1328
Metabolomic profiling in the prediction of gestational diabetes mellitus Rhonda Bentley-LewisJennifer HuynhRobert Gerszten Short Communication 07 March 2015 Pages: 1329 - 1332
Beta cell response to nutrient overload involves phospholipid remodelling and lipid peroxidation Guy CohenOfer ShamniShlomo Sasson Article 26 March 2015 Pages: 1333 - 1343
Caveolin-1 phosphorylation regulates vascular endothelial insulin uptake and is impaired by insulin resistance in rats Hong WangAileen X. WangEugene J. Barrett Article 10 March 2015 Pages: 1344 - 1353
Delayed timing of post-challenge peak blood glucose predicts declining beta cell function and worsening glucose tolerance over time: insight from the first year postpartum Caroline K. KramerChang YeRavi Retnakaran Article 12 March 2015 Pages: 1354 - 1362
Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes Helen C. LookerMarco Colomboon behalf of the SUMMIT Investigators Article 05 March 2015 Pages: 1363 - 1371
Co-ordinating meals and exercise for diabetes management Elsamma Chacko Letter 03 April 2015 Pages: 1372 - 1373
Within-class differences of the sulfonylureas should be accounted for Dennis SchrijndersNanne KleefstraGijs W. D. Landman Letter 24 March 2015 Pages: 1374 - 1375
Within-class differences of the sulfonylureas should be accounted for. Reply to Schrijnders D, Kleefstra N and Landman GWD [letter] Jonathan C. LevyAxel RiefflinRury R. Holman Letter 26 March 2015 Pages: 1376 - 1377
Impact of cancer on use of glucose-lowering drug treatment in individuals with diabetes: potential mechanisms Frans Pouwer Letter 13 March 2015 Pages: 1378 - 1379
Impact of cancer on use of glucose-lowering drug treatment in individuals with diabetes: potential mechanisms. Reply to Pouwer F [letter] Marjolein M. J. ZandersHarm R. HaakJeffrey A. Johnson Letter 03 April 2015 Pages: 1380 - 1381